Strength training during later-line pancreatic or biliary cancer therapy

MS-N177 · Exercise and rehabilitation · stage IV pancreatic or biliary-tract cancer receiving treatment beyond first line

Evidence at a glance

Question: Can supervised plus home strength training preserve function and symptoms during later-line therapy?
Finding: A small pilot found better strength performance and some symptom signals, but global quality-of-life differences were not significant.
Evidence label: Preliminary positive functional signal
Benefit: Four strength/function measures favored exercise at eight weeks.
Certainty: Low: small, single-center, unblinded trial with multiple outcomes and incomplete follow-up.
Risk: No adverse event was judged exercise-related; serious events from advanced cancer and treatment occurred in both groups.
Cancer-control boundary: This trial did not establish tumor response or survival benefit.

What was studied

Adults with stage III–IV pancreatic or biliary cancer, ECOG 0–2, starting treatment beyond first line and expected to live at least three months.

Design and comparator: Single-center randomized pilot; three exercise sessions weekly versus physical-activity recommendations.
Participants: 41 randomized (20 intervention, 21 control); patient-reported outcome table included 31.
Intervention: Eight weeks: one supervised strength session plus two individualized home sessions each week.
Primary outcome and follow-up: Feasibility—recruitment, adherence, dropout and safety; strength, function, fatigue, constipation and quality of life were exploratory.

What the study found

At eight weeks, leg press (P=.001), bench press (P=.011), sit-to-stand (P=.001) and abdominal crunch (P=.006) favored exercise. Constipation favored exercise (P=.033), while fatigue improved within the intervention group (P=.028). Overall global quality of life was not significantly different between groups.

Negative or uncertain findings: Many outcomes were tested without a definitive efficacy primary endpoint; global quality of life was not significantly better. Very small subgroup findings are hypothesis-generating.

Limits and applicability

Small sample, advanced-disease attrition, unblinded outcomes and multiple comparisons increase false-positive risk. Participants with unstable cardiopulmonary disease or unsafe bone metastases were excluded.

Funding and conflicts: Commercial funding was not identified in the extracted report. Several authors reported oncology-industry relationships outside the submitted work.

Safety context

Advanced pancreatic/biliary cancer carries high risks of cachexia, thrombosis, infection, ascites and rapid change. Exercise should be modified for pain, cytopenias, biliary obstruction, unstable bone disease and falls.

Questions for the care team

Is the immediate goal strength, fatigue, independence or symptom control?
Are there bone lesions, thrombosis or cardiopulmonary risks that change the plan?
Can an oncology physiotherapist supervise the first sessions?

Primary sources

Last literature search: 29 October 2026. Record appraisal: 29 October 2026. This page is educational and does not replace individualized medical advice. Exercise prescriptions should be adapted to diagnosis, treatment, surgical restrictions, blood counts, cardiopulmonary status, neuropathy, fall risk and bone-metastasis location. Symptom or fitness improvement is not proof of tumor response, recurrence prevention or longer survival unless those outcomes were directly tested.